Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members-Reference-Cited by-同舟云学术

Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members

Published:2020-10 Issue:10 Volume:38 Page:796.e1-796.e6
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Matulay Justin T.,Tabayoyong William,Duplisea Jonathan J.,Chang Courtney,Daneshmand Siamak,Gore John L.,Holzbeierlein Jeffrey M.,Karsh Lawrence I.,Kim Simon P.,Konety Badrinath R.,Li Roger,McKiernan James M.,Messing Edward M.,Steinberg Gary D.,Williams Stephen B.,Kamat Ashish M.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. Diagnosis and treatment of non-muscle nvasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

2. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

3. Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries;Lancet,2017

4. Projections of the cost of cancer care in the United States: 2010-2020;Mariotto;J Natl Cancer Inst,2011

5. Cost implications of the rapid adoption of newer technologies for treating prostate cancer;Nguyen;J Clin Oncol,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over Time;Urology;2024-07

2. The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer;The Journal of Molecular Diagnostics;2024-04

3. Editorial comment—Risk stratification and management of nonmuscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories;International Journal of Urology;2023-11-15

4. Accurate Documentation Contributes to Guideline-concordant Surveillance of Nonmuscle Invasive Bladder Cancer: A Multisite Department of Veterans Affairs Study;Urology;2023-11

5. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs;Frontiers in Oncology;2023-06-02